Key Insights

Highlights

Success Rate

98% trial completion (above average)

Research Maturity

51 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.9%

1 terminated out of 107 trials

Success Rate

98.1%

+11.5% vs benchmark

Late-Stage Pipeline

6%

6 trials in Phase 3/4

Results Transparency

16%

8 of 51 completed with results

Key Signals

8 with results98% success

Data Visualizations

Phase Distribution

75Total
Not Applicable (66)
P 1 (1)
P 2 (2)
P 3 (5)
P 4 (1)

Trial Status

Completed51
Recruiting16
Not Yet Recruiting14
Unknown10
Active Not Recruiting7
Withdrawn6

Trial Success Rate

98.1%

Benchmark: 86.6%

Based on 51 completed trials

Clinical Trials (107)

Showing 20 of 20 trials
NCT07788755Not ApplicableNot Yet Recruiting

NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia

NCT06612190Not ApplicableActive Not RecruitingPrimary

Evaluation on Visual Outcome of TMS

NCT05844982Phase 3Recruiting

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

NCT07741500Not ApplicableNot Yet RecruitingPrimary

Body Image, Identity Development, and Social Media Use Among Youth With Visual Impairment: A Single Case Intervention Study

NCT07717671Not ApplicableNot Yet RecruitingPrimary

VIPPSTAR-G1 Digital Early Intervention for Visual Impairment

NCT07703150Not ApplicableNot Yet RecruitingPrimary

Promoting Psychophysical Well-being in Children and Adolescents With Visual Impairment

NCT07694505Not Yet RecruitingPrimary

Survey of Sensory Impairment Indicators Among Adults Aged 65 Years and Older in Xinxing County

NCT06075147Active Not RecruitingPrimary

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

NCT07665047Not Yet RecruitingPrimary

Assessment of Caries Impacts and Experiences in a Visually Impaired Versus Sighted Children Using CARIES-QC/A

NCT07641127Not ApplicableCompletedPrimary

Digital Twin Smart Educational Platform for Visually Impaired Navigation Training

NCT05199896Not ApplicableRecruitingPrimary

Touching the World With a Cane: Cognitive and Neural Processes

NCT06241209Not ApplicableRecruiting

Hemianopsia Rehabilitation After Stroke or Brain Injury

NCT06877988Not ApplicableActive Not RecruitingPrimary

Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation of Performance, Feasibility and Costs.

NCT06604104Recruiting

Visual Frailty in Ageing

NCT05085210Not ApplicableRecruiting

Improving Visual Field Deficits With Noninvasive Brain Stimulation

NCT07442461Not ApplicableNot Yet RecruitingPrimary

Virtual Assistance for Daily Living: Neurophysiological and Functional Effects in Low Vision

NCT06934577Not ApplicableRecruiting

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

NCT05028712Not ApplicableRecruiting

Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision

NCT06984822Not ApplicableRecruiting

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

NCT06616051Not ApplicableCompletedPrimary

Frequency of Visual Impairment Among School Children and Effectiveness of mHealth Referral Reminder on Uptake of Referral Services

Scroll to load more

Research Network

Activity Timeline